|Bid||72.46 x 100|
|Ask||74.25 x 100|
|Day's Range||74.11 - 75.64|
|52 Week Range||55.80 - 83.49|
|PE Ratio (TTM)||12.35|
|Earnings Date||Feb 27, 2018|
|Forward Dividend & Yield||0.00 (0.00%)|
|1y Target Est||81.88|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
An Irish drugmaker has put a price tag of almost $3,000 on a bottle of two-in-one painkillers that can be bought separately for $36, in another instance of gouging in the US, the world’s largest healthcare ...
The trio will have to take on drugmakers, PBMs, insurers, and pharmacy chains to bring down the high price of medicines.
Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.
Middlemen that negotiate drug discounts are under fire from drugmakers who say that secret rebates aren’t always shared with patients.
ST. LOUIS , Feb. 6, 2018 /PRNewswire/ -- At a time when consumers, businesses and policymakers are intensely focused on reducing prescription drug costs, Express Scripts (NASDAQ: ESRX) helped employers ...
Neal Sample has been promoted from Chief Information Officer to Chief Operating Officer of Express Scripts. Prior to his time at Express Scripts, Sample had been the President of Enterprise Growth at American Express.
FRANKLIN LAKES, N.J., Feb. 5, 2018 /PRNewswire/ -- Inside Rx today announced that it is now offering better pricing on the brand and generic versions of Tamiflu® (oseltamivir phosphate) to help Americans affected by what the Centers for Disease Control and Prevention (CDC) has called the worst recorded influenza season in almost a decade. Launched last year by Express Scripts (ESRX), the Inside RxSM prescription savings program can provide deeper savings to people who pay full-list price for prescription medications.
Shares of Express Scripts Holding Company (NASDAQ: ESRX ) have risen more than 30 percent since Thanksgiving 2017, mostly due to expectations of earnings improvements stemming from U.S. tax legislation. ...
Health care stocks ended Tuesday's session mostly lower after three of America's most notable CEOs announced a collaboration to explore ways of improving employee health care services and slashing costs. ...
Investors seemed unsure which health-care stock to sell first, after today’s announcement of a medical cost-containment venture by Berkshire Hathaway (ticker:ticker::BRK.A), Amazon.com (AMZN), and JPMorgan Chase (JPM). The three firms gave few details about how they’ll try to cut their medical bills, but this morning’s selloff implied that Wall Street fears most for the profits of pharmacy businesses like Express Scripts Holding (ESRX), and health insurers like Cigna (CI) and Anthem (ANTM). It’s a good guess that the trio will start by targeting pharmacy spending and the profit margins of Express Scripts, CVS Health (CVS), and Walgreens Boots Alliance (WBA) as have other employer alliances aimed at health-care costs.
The U.S. Securities and Exchange Commission will review a dispute between Express Scripts Holding Co. and New York State Comptroller Thomas DiNapoli over his effort to force the prescription-benefits manager ...
- Inside Rx Generated $35 Million in Savings Since May 2017 - 30 new brand medications for weight loss, dermatology, gastrointestinal conditions and allergies now available FRANKLIN LAKES, N.J. , Jan. ...
Louis, Jan. 15, 2018-- Express Scripts Holding Company announced today its intention to release its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018, after the market closes ...
WASHINGTON, Jan. 11, 2018 /PRNewswire/ -- During a briefing on meaningful solutions for safer opioid prescribing with Congressional Representatives Ann McLane Kuster (D-NH) and Tom MacArthur (R-NJ), Express Scripts (ESRX) today announced that an initial 90-day review of its Advanced Opioid ManagementSM program shows that the comprehensive solution is protecting people using an opioid medication, particularly those taking an opioid for the first time. In the first 90 days since the program began on September 1, 2017, the company observed a nearly 60 percent reduction in the average days supply for patients receiving an opioid prescription for the first time, from 18.6 days supply per prescription claim before the launch of the program, to 7.5 days supply per claim after the start of the program.
ST. LOUIS , Jan. 10, 2018 /PRNewswire/ -- Accredo ® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), has earned URAC's specialty pharmacy accreditation at its primary dispensing locations: ...
FRANKLIN LAKES, N.J. , Jan. 10, 2018 /PRNewswire/ -- Inside Rx, which administers a prescription savings program for the uninsured and underinsured, is helping more people access savings to prescription ...
How far off is Express Scripts Holding Company (NASDAQ:ESRX) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stockRead More...
Jan.09 -- Express Scripts CEO Tim Wentworth discusses mergers and acquisitions in the healthcare industry. He speaks with Bloomberg's Erik Schatzker at the J.P. Morgan Healthcare Conference in San Francisco.